Glycine is the major inhibitory neurotransmitter in the brainstem and spinal cord, where it functions at specific strychnine-sensitive glycine receptors. In addition, glycine participates in excitatory neurotransmission as an essential co-agonist of glutamate at N-methyl-D-aspartate (NMDA) receptor containing synapses; therefore, NMDA receptor activation is tightly modulated by the activity of the plasma membrane glycine transporter 1 (GlyT1) present in presynaptic neurons and neighboring glial cells. Altered numbers of functional NMDA receptors have been suggested to underlie some of the symptoms in schizophrenia, primarily in cognitive functions. The GlyT1 has been the main target for drug development in schizophrenia; however, how the transporter is regulated remains poorly understood. It is known for several members of the monoamine transporter family that transport activity is linked to activation of Protein Kinase C (PKC); however, the mechanism of regulation is controversial or unknown in the brain. Given the strength of clinical and pharmacological data suggesting glutamate receptor dysfunction in schizophrenia and the role of the glycine transporter as a potential drug target, in this study our goal is to characterize the regulatory mechanism of the GlyT1 using two expression systems: (a) mouse GlyTIa expressed in model cell lines (HeLa and Porcine Aortic Endothelial cells, PAE) and (b) endogenous GlyT1 in primary cultures from rat hippocampus. Based on preliminary data from our laboratory that suggest enhanced PKC-dependent ubiquitination and endocytosis obtained by expressing GlyT1 in HeLa cells, we hypothesize that PKC activation results in GlyT1 ubiquitination and down-regulation in the brain, contributing to the regulation of the glycine transporter. This research will offer new potential pharmacological targets to treat neurological disorders, such as schizophrenia. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Enhancement Award (SC1)
Project #
1SC1MH086070-01
Application #
7499296
Study Section
Special Emphasis Panel (ZGM1-MBRS-X (CB))
Program Officer
Nadler, Laurie S
Project Start
2008-09-15
Project End
2012-07-31
Budget Start
2008-09-15
Budget End
2009-07-31
Support Year
1
Fiscal Year
2008
Total Cost
$283,040
Indirect Cost
Name
University of Texas El Paso
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
132051285
City
El Paso
State
TX
Country
United States
Zip Code
79968
Barrera, Susana P; Castrejon-Tellez, Vicente; Trinidad, Margarita et al. (2015) PKC-Dependent GlyT1 Ubiquitination Occurs Independent of Phosphorylation: Inespecificity in Lysine Selection for Ubiquitination. PLoS One 10:e0138897
Sierra-Fonseca, Jorge A; Najera, Omar; Martinez-Jurado, Jessica et al. (2014) Nerve growth factor induces neurite outgrowth of PC12 cells by promoting G??-microtubule interaction. BMC Neurosci 15:132
Shpak, Max; Gentil, Luciana Girotto; Miranda, Manuel (2014) The origin and evolution of vertebrate glycine transporters. J Mol Evol 78:188-93
Robles-Martínez, Leobarda; Pardo, Juan Pablo; Miranda, Manuel et al. (2013) The basidiomycete Ustilago maydis has two plasma membrane H?-ATPases related to fungi and plants. J Bioenerg Biomembr 45:477-90
Pal, Rituraj; Miranda, Manuel; Narayan, Mahesh (2011) Nitrosative stress-induced Parkinsonian Lewy-like aggregates prevented through polyphenolic phytochemical analog intervention. Biochem Biophys Res Commun 404:324-9
Miranda, Manuel; Pardo, Juan Pablo; Petrov, Valery V (2011) Structure-function relationships in membrane segment 6 of the yeast plasma membrane Pma1 H(+)-ATPase. Biochim Biophys Acta 1808:1781-9
Vargas-Medrano, Javier; Castrejon-Tellez, Vicente; Plenge, Fernando et al. (2011) PKC?-dependent phosphorylation of the glycine transporter 1. Neurochem Int 59:1123-32